4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-002655
Senior VP, Chief Pharma Dev. sold 103 shares at $335.24 ($34,530)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2025-01-24 | Sale | −103 | $335.24 | $34,530 | 4,955 | D |
| Open-market sales · 103 sh · avg $335.24 · $34,530 | |||||||
Loading xslF345X05/wk-form4_1738015378.xml…